AP Pharma Inc. (APPA) Swings To Q4 Profit
AP Pharma Inc. (NASDAQ: APPA) reported Q4 EPS of $0.04, versus ($0.05) last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Accenture (ACN) Tops Q1 EPS by 9c; Guides Q2 Revs; Offers FY15 Outlook Update
- Winnebago Industries, Inc. (WGO) Misses Q1 EPS by 8c
- Rite Aid (RAD) Tops Q3 EPS by 5c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!